Prevention or reversal of sensorineural hearing loss (SNHL) through biologic mechanisms
AssigneeThe United States of America as represented by the Secretary of the Navy
InventorsRichard D. Kopke, Donald Henderson, Michael E. Hoffer
Life of this patent
Estimating the term…
Abstract
The invention presents methods for preventing and treating sensorineural hearing loss and is directed to the restoration or protection of hair cells in individuals experiencing a non-presbycusis type sensorineural hearing loss or who are at risk for an acute hearing loss due to exposure to noise, toxins, or other stressors. More specifically, the present invention relates to the use of agents which augment inner ear antioxidant defenses (e.g. acetyl-L-carnitine, steroids, compounds that are transported into inner ear hair cells and then synthesized by said cells into glutahione) to prevent and/or reverse hearing loss induced by noise, toxins, or other stressors.
Claims8
A method for preventing and treating noise or toxin induced sensorineural hearing loss, comprising:
- (a) selecting subjects experiencing said hearing loss or at risk for acute exposure to noise, toxins, or other stressors causing said hearing loss;
- and
- (b) administering to said subjects a pharmaceutically effective amount of a compound selected from the group consisting of:
- steroids;
- compounds that are transported into inner ear hair cells and then synthesized by said cells into glurathione;
- and
- combinations thereof.
A method for preventing and treating sensorineural hearing lass, comprising:
- (c) selecting subjects experiencing said hearing loss or at risk for acute exposure to noise, toxins, or other stressors causing said hearing loss;
- and
- (d) administering to said subjects a pharmaceutically effective amount of a mixture of compounds selected from the group consisting of:
- N-L-acetylcysteine;
- an ester of salicylic acid;
- a salt of salicylic acid;
- and
- any combination thereof.
A method for preventing and treating non-presbycusis related hearing loss, comprising:
- (a) selecting subjects experiencing said hearing loss or at risk for acute exposure to noise, toxins, or other stressors causing said hearing loss;
- and
- (b) administering to said subjects a pharmaceutically effective amount of aectyl-L-carnitine.
Dependencies are inferred from the claim text.